Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys

Free Radic Biol Med. 2017 May:106:393-405. doi: 10.1016/j.freeradbiomed.2017.03.003. Epub 2017 Mar 10.

Abstract

Our previous study indicated that Casein kinase 2 interacting protein-1 (CKIP-1) could promote the activation of the nuclear factor E2-related factor 2 (Nrf2)/ antioxidant response element (ARE) pathway, playing a significant role in inhibiting the fibrosis of diabetic nephropathy (DN). Polydatin (PD) has been shown to possess strong resistance effects on renal fibrosis which is closely related to activating the Nrf2/ARE pathway, too. Whereas, whether PD could resist DN through regulating CKIP-1 and consequently promoting the activation of Nrf2-ARE pathway needs further investigation. Here, we found that PD significantly reversed the down-regulation of CKIP-1 and attenuated fibronectin (FN) and intercellular cell adhesion molecule-1 (ICAM-1) in glomerular mesangial cells (GMCs) exposed to high glucose (HG). Moreover, PD could decrease Keap1 expression and promote the nuclear content, ARE-binding ability, and transcriptional activity of Nrf2. The activation of Nrf2-ARE pathway by PD eventually led to the quenching of hydrogen peroxide (H2O2) and superoxide overproduction boosted by HG. Depletion of CKIP-1 blocked the Nrf2-ARE pathway activation and reversed FN and ICAM-1 down-regulation induced by PD in GMCs challenged with HG. PD increased CKIP-1 and Nrf2 levels in the kidney tissues as well as improved the anti-oxidative effect and renal dysfunction of diabetic mice, which eventually reversed the up-regulation of FN and ICAM-1. Experiments above suggested that PD could increase the CKIP-1-Nrf2-ARE pathway activation to prevent the OSS-induced insult in GMCs and diabetic mice which effectively postpone the diabetic renal fibrosis and the up-regulation of CKIP-1 is probably a novel mechanism in this process.

Keywords: CKIP-1; Diabetic nephropathy; Keap1; Nrf2/ARE pathway; Oxidative stress; Polydatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Carboxylic Ester Hydrolases / genetics
  • Carboxylic Ester Hydrolases / metabolism
  • Carrier Proteins / antagonists & inhibitors
  • Carrier Proteins / genetics*
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / pathology
  • Fibronectins / genetics*
  • Gene Expression Regulation / drug effects
  • Glucose / toxicity
  • Glucosides / administration & dosage
  • Humans
  • Hydrogen Peroxide / metabolism
  • Intercellular Adhesion Molecule-1 / genetics*
  • Kelch-Like ECH-Associated Protein 1 / genetics
  • Mesangial Cells / drug effects
  • Mesangial Cells / metabolism
  • Mesangial Cells / pathology
  • Mice
  • Mice, Inbred NOD
  • NF-E2-Related Factor 2 / genetics*
  • NF-E2-Related Factor 2 / metabolism
  • Signal Transduction / drug effects
  • Stilbenes / administration & dosage
  • Superoxides / metabolism

Substances

  • Antioxidants
  • CKIP-1 protein, mouse
  • Carrier Proteins
  • Fibronectins
  • Glucosides
  • Keap1 protein, mouse
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Stilbenes
  • Superoxides
  • Intercellular Adhesion Molecule-1
  • Hydrogen Peroxide
  • Carboxylic Ester Hydrolases
  • arylesterase
  • Glucose
  • polydatin